Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

81.99
BATS BZX Real-Time Price
As of 1:03pm ET
 +0.52 / +0.64%
Today’s Change
77.92
Today|||52-Week Range
113.31
-18.97%
Year-to-Date
Gilead Sciences (GILD) Stock Price Target Cut, Leerink: Weak HIV Sales
11:26am / TheStreet.com - Paid Partner Content
Gilead (GILD) Stock Lower, Piper Jaffray: Little Required to 'Driver Shares Higher'
Aug 16 / TheStreet.com - Paid Partner Content
Why You Should (and Shouldn't) Buy Gilead Sciences, Inc.
8:09am / MotleyFool.com - Paid Partner Content
4 Top Biotech Stocks That Can Be Purchased on the Cheap This Summer
Aug 16 / MotleyFool.com - Paid Partner Content
Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Aug 23 / Zacks.com - Paid Partner Content
These 3 Hated Dividend Stocks Look Like Buys
Aug 14 / MotleyFool.com - Paid Partner Content
Galapagos (GLPG) Advances RA Drug Filgotinib to Phase III
Aug 23 / Zacks.com - Paid Partner Content
Could Gilead Sciences Face an Unexpected $10 Billion Tax Bill?
Aug 13 / MotleyFool.com - Paid Partner Content
3 Cheap Healthcare Stocks Paying Dividends Now
Aug 23 / MotleyFool.com - Paid Partner Content
How Will Gilead (GILD) Stock React to Hepatitis-C Drug Prescriptions?
Aug 12 / TheStreet.com - Paid Partner Content
Advanced Micro Devices and the Three Year Gamble
Aug 22 / GuruFocus News - Paid Partner Content
Healthcare Dividend Growth Stocks: Part 1
Aug 12 / GuruFocus News - Paid Partner Content
Here's Why a Gilead Stock Split Is Unlikely
Aug 22 / MotleyFool.com - Paid Partner Content
Should Gilead Split in Two?
Aug 12 / TheStreet.com - Paid Partner Content
ETFs in Focus on Pfizer's Medivation Acquisition
Aug 22 / Zacks.com - Paid Partner Content
Analysts: Gilead Should Divide Itself and Conquer
Aug 12 / TheStreet.com - Paid Partner Content
Biotechs Continue to Lead a Listless Market
Aug 22 / TheStreet.com - Paid Partner Content
ETFs to Watch as Nasdaq Hits All-Time High
Aug 09 / Zacks.com - Paid Partner Content
10 Low PE Stock Picks for the Enterprising Investor - August
Aug 22 / GuruFocus News - Paid Partner Content
Gilead Sciences Inc. Stock in 3 Charts
Aug 09 / MotleyFool.com - Paid Partner Content
Pfizer nears $14bn takeover of Medivation
Aug 21 / FT.com - Paid Partner Content
Stock Market News for August 09, 2016
Aug 09 / Zacks.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Licensing Agreements Drive Ligand Pharmaceuticals Inc. 13% Higher in July
Aug 08 / MotleyFool.com - Paid Partner Content
Top Undervalued Stocks to Buy in 2016
Aug 21 / MotleyFool.com - Paid Partner Content
Are Gilead Sciences' Best Days Behind It?
Aug 07 / MotleyFool.com - Paid Partner Content
Gilead Sciences (GILD) Stock Up, Piper Jaffray: Splitting Is 'Poor Idea'
Aug 19 / TheStreet.com - Paid Partner Content
Ligand (LGND) Q2 Earnings Decline Y/Y, Maintains View
Aug 05 / Zacks.com - Paid Partner Content
Gilead May Be Better Off Splitting Itself in Two, Analysts Say
Aug 18 / TheStreet.com - Paid Partner Content
Health service chiefs to challenge HIV drug ruling
Aug 02 / FT.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
Stocks: 5 things to know before the open
Jul 26 / CNNMoney.com
3 Cheap Stocks for Rookie Investors to Start With
Aug 17 / MotleyFool.com - Paid Partner Content
Stocks: 5 things to know before the open
Jul 25 / CNNMoney.com